Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis

Background: The occurrence of acne in patients treated with Janus kinase (JAK) inhibitors for skin diseases is a potential issue, which may reduce treatment adherence.